期刊文献+

多奈哌齐治疗血管性痴呆伴失语症的疗效观察 被引量:2

下载PDF
导出
摘要 目的评价盐酸多奈哌齐治疗血管性痴呆(VD)伴失语症的疗效。方法将55例VD伴失语症患者随机分为盐酸多奈哌齐组(治疗组)27例和曲克芦丁组(对照组)28例。治疗组用盐酸多奈哌齐,5 mg/d,连用12 w;对照组用曲克芦丁,120 mg/次,3次/d,连用12 w。采用简易精神状态量表(MMSE)、改良巴氏指数评定表(MBI)及波士顿诊断性失语检查法(BDAE)失语严重程度分级评定疗效。结果治疗12 w后,治疗组与对照组比较MMSE、MBI和BDAE失语严重程度分级总分评定差异有统计学意义。治疗期间两药不良反应均轻微,患者易耐受。结论盐酸多奈哌齐治疗VD伴失语症安全、有效。
作者 朱宁 刘合玉
出处 《中国老年学杂志》 CAS CSCD 北大核心 2008年第9期905-906,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献6

  • 1于宝成,王玉敏,魏士贤.脑血管危险因素与Alzheimer病[J].国外医学(脑血管疾病分册),2003,11(5):374-376. 被引量:32
  • 2Albert ML, Bachman DL, Morgan A, el al. Pharmacotherapy for aphasia [ J ]. Neurology, 1988 ; 3 : 877-9.
  • 3Tanaka Y, Miyazaki M, Albert ML. Effects of increased cholinergic activity on naming in aphasia[J]. Lancet,1997 ;350:116-7.
  • 4Meyer JS, Chowdhury MH, Xu G, et al. Donepezil treatment of vascular dementia[ J]. Ann N Y Acad Sci,2002 ;977:482-6.
  • 5Pratt RD. Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vasculal dementia[J]. J Neurol Sci, 2002 ;203:57-65.
  • 6Black S, Rroman GC, Geldmacher DS, et al. Efficacy and tolerability of Donepezil in vascular dementia: positive results of a 24-week, multi-center,international,randomized,placebo-trolled clinical trial [J]. Stroke, 2003 ;34 ( 10 ) :23-30.

二级参考文献19

  • 1Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon 4 allele, elevated midlffe total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzhekner disease. Ann Intern Med, 2002. 137:149 - 155.
  • 2Meyer JS, Rauch G, Rauch RA, et al. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Nenrobiol Aging, 2000, 21 : 161 - 169.
  • 3Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet, 1996, 347:1141 - 1145.
  • 4Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brah weight at death: the HAAS. Honokdu-Asia aging Study. Neurobiol Aging, 2000, 21:57 -62.
  • 5de la Torre JC. Cerebral hypoperfusion, capiliary degeneration, and development of Alzhehner disease. Alzheimer Dis Assoc Disord, 2000,14(Suppl 1): S72 -S81.
  • 6Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology, 1998, 51:986 -993.
  • 7DeCarli C, Murphy DG, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose m 51 healthy adults. Neurology, 1995,45: 2077 - 2084.
  • 8Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 1993, 261:921 -923.
  • 9Zarow C, Zaias B, Lyness SA, et al. Cerebral amyioid angiopathy Alzhehner disease is associated with apolipoprotein E4 and cortical neuron loss. Alzheimer Dis Assoc Disord, 1999, 13:1 -8.
  • 10Kosunen O, Talasniemi S, Lehtovirta M, et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.Stroke, 1995, 26:743 -748.

共引文献31

同被引文献35

  • 1孙忠人,霍立光,刘丽莉,李淑兰.头皮针刺运动诱发电位的研究[J].中国中医药科技,1994,1(6):14-18. 被引量:29
  • 2曹京波,赵纯,金旻,张玉梅.失语症的常用评价方法[J].中国临床康复,2006,10(18):139-141. 被引量:29
  • 3王桂荣,施宇,赵明慧.脑卒中失语患者早期语言康复训练的效果[J].中国康复,2007,22(2):117-117. 被引量:11
  • 4Berthier ML. Poststroke aphasia :epidemiology pathophysiology andtreatment [J]. Drugs Aging,2005,22 :163 - 182.
  • 5Goodglass H,Kaplan E. The assessment of aphasia and related dis-orders [M ]. Second edition. Philadelphia USA. Lea & Febiger,1983:5 -11.
  • 6Reed DA,Johnson NA,Thompson C,et al. A clinical trial of bro-mocriptine for treatment of primary progressive aphasia [ J]. AnnNeurol’2004,56:750.
  • 7Ashtary F,Janghorbani M,Chitsaz A,et al. A randomized,double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke[J]. Neurology,2006,66:914 -916.
  • 8Seniow J,Litwin T. New approach to the rehabilitation of post -stroke focal cognitive syndrome :effect of Ievodopa combined withspeech and language therapy on functional recovery from aphasia[J]. Neurol Sci,2009,283:214 -218.
  • 9Whiting E,Chenery HJ,Chalk J,et al. Dexamphetamine boosts na-ming treatment effects in chronic aphasia[ J]. Int Neuropsychol Sic,2007,13:972 -979.
  • 10Hughes JD,Jacobs DH,Heilman KM. Neuropharmacology and lin-guistic neuroplasticity[ J]. Brain Lang,2000,71:96 - 101.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部